Related by context. Frequent words. (Click for all words.) 77 cytogenetic response 71 RECIST criteria 71 sustained virologic response 70 virologic failure 69 annualized relapse 69 mg kg dose 69 plus methotrexate 68 mg QD 68 plus dexamethasone 68 virologic response 68 nilotinib 68 dasatinib 67 evaluable 67 complete remissions 66 mg BID 66 DAS# [002] 66 Median survival 66 Ph + ALL 66 RECIST 66 Fludara 66 FOLFOX 66 evaluable patients 65 neoadjuvant 65 mycophenolate mofetil 65 peginterferon 65 EBRT 65 neoadjuvant chemotherapy 65 median PFS 65 Secondary endpoints include 65 Solid Tumors 65 Secondary endpoints included 64 Combination therapy 64 undetectable viral load 64 decitabine 64 FOLFIRI 64 adalimumab 64 peginterferon alfa 2a 64 estimated glomerular filtration 64 DMARD 64 XELOX 64 statistically significant p = 64 azacitidine 64 nonresponders 63 placebo p = 63 plus prednisone 63 noninferiority 63 serum phosphorus 63 Secondary endpoints 63 lymphopenia 63 mcg dose 63 tumor lysis syndrome 63 peginterferon alfa 2b 63 plus ribavirin 63 chemoradiotherapy 63 adefovir 63 plus gemcitabine 63 mcg kg 63 fluorouracil 63 febrile neutropenia 63 seroconversion 63 free survival PFS 63 dacarbazine 63 HbA1c levels 63 tolvaptan 63 laboratory abnormalities 63 COPAXONE R 62 tumor recurrence 62 mitoxantrone 62 achieved statistical significance 62 COPD exacerbations 62 imatinib 62 tumor shrinkage 62 tocilizumab 62 #mg dose [001] 62 peg IFN 62 administered subcutaneously 62 nab paclitaxel 62 P = .# 62 DMARDs 62 CI -#.# 62 nonsignificant 62 tipranavir 61 androgen deprivation 61 secondary efficacy endpoints 61 serum concentrations 61 Arch Intern Med 61 tumor regression 61 ADAS cog 61 % CI #.#-#.# [006] 61 systemic embolism 61 distant metastases 61 antibody titers 61 neoadjuvant therapy 61 PEG Intron 61 cabazitaxel 61 copies mL 61 interferon alfa 61 LVEF 61 limiting toxicity 61 fibrinolysis 61 tamoxifen therapy